Liver Illness and Psoriatic Patients

被引：60
作者：
Fiore, Marco [1 ]
Leone, Sebastiano [2 ]
Maraolo, Alberto Enrico [3 ]
Berti, Emilio [4 ]
Damiani, Giovanni [4 ,5 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Anaesthesiol Surg & Emergency Sci, Naples, Italy
[2] San Giuseppe Moscati Hosp, Dept Med, Div Infect Dis, Avellino, Italy
[3] Univ Naples Federico II, Dept Clin Med & Surg, Sect Infect Dis, Naples, Italy
[4] Univ Milan, IRCCS Ca Granda, Dept Pathophysiol & Transplantat, Dermatol Unit, Milan, Italy
[5] Study Ctr Young Dermatologists Italian Network YD, Bergamo, Italy
来源：
BIOMED RESEARCH INTERNATIONAL | 2018年 / 2018卷
关键词：
HEPATITIS-B-VIRUS; GENERALIZED PUSTULAR PSORIASIS; PRIMARY BILIARY-CIRRHOSIS; FACTOR-ALPHA INHIBITORS; C VIRUS; RHEUMATOID-ARTHRITIS; IMMUNOSUPPRESSED PATIENTS; HEPATOCELLULAR-CARCINOMA; RETROSPECTIVE ANALYSIS; CLINICAL-PRACTICE;
D O I：
10.1155/2018/3140983
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Psoriasis is a chronic inflammatory disease of the skin affecting approximately 2% of the world's population. Systemic treatments, including methotrexate and cyclosporin, are associated with potential hepatotoxicity, due to either direct liver damage or immunosuppression or both immunomediated and a direct liver injury; therefore, treatment of patients with psoriasis poses a therapeutic challenge. The aim of this minireview is to help clinicians in the management of psoriatic patients who develop signs of liver dysfunction. To find relevant articles, a comprehensive search was performed on PubMed, EMBASE, and Cochrane with appropriate combinations of the following keywords being considered: viral hepatitis, nonalcoholic fatty liver disease, psoriasis, hepatotoxicity, drug toxicity, cholestasis, and autoimmune liver diseases.
引用
收藏
页数：12
相关论文
共 129 条
  • [1] Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management
    Abramson, Amanda
    Menter, Alan
    Perrillo, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) : 1349 - 1361
  • [2] Nonalcoholic fatty liver disease
    Adams, LA
    Angulo, P
    Lindor, KD
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) : 899 - 905
  • [3] Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model
    Al-Harbi, Naif O.
    Nadeem, Ahmed
    Al-Harbi, Mohammed M.
    Zoheir, Khairy M. A.
    Ansari, Mushtaq A.
    El-Sherbeeny, Ahmed M.
    Alanazi, Khalid M.
    Alotaibi, Moureq R.
    Ahmad, Sheikh F.
    [J]. IMMUNOBIOLOGY, 2017, 222 (02) : 128 - 136
  • [4] Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis
    Allez, M
    Roux, ME
    Bertheau, P
    Erlinger, S
    Degott, C
    Morel, P
    Modigliani, R
    Rybojad, M
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (01) : 160 - 162
  • [5] Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate
    Amital, Howard
    Arnson, Yoav
    Chodick, Gabriel
    Shalev, Varda
    [J]. RHEUMATOLOGY, 2009, 48 (09) : 1107 - 1110
  • [6] The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis
    An, Jingang
    Zhang, Dingwei
    Wu, Jiawen
    Li, Jiong
    Teng, Xiu
    Gao, Xiaomin
    Li, Ruilian
    Wang, Xiuying
    Xia, Linlin
    Xia, Yumin
    [J]. PHARMACOLOGICAL RESEARCH, 2017, 121 : 158 - 168
  • [7] High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C
    Aroucha, D. C. B. L.
    do Carmo, R. F.
    Moura, P.
    Silva, J. L. A.
    Vasconcelos, L. R. S.
    Cavalcanti, M. S. M.
    Muniz, M. T. C.
    Aroucha, M. L.
    Siqueira, E. R. F.
    Cahu, G. G. O. M.
    Pereira, L. M. M. B.
    Coelho, M. R. C. D.
    [J]. CYTOKINE, 2013, 62 (03) : 421 - 425
  • [8] Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis
    Barak, V.
    Selmi, C.
    Schlesinger, M.
    Blank, M.
    Agmon-Levin, N.
    Kalickman, I.
    Gershwin, M. E.
    Shoenfeld, Y.
    [J]. JOURNAL OF AUTOIMMUNITY, 2009, 33 (3-4) : 178 - 182
  • [9] Hepatitis Caused by Lotus-f3?
    Bergman, Jenny
    Schjott, Jan
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (05) : 414 - 416
  • [10] Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations
    Bessone, Fernando
    Dirchwolf, Melisa
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (08) : 385 - 394
12345678910